These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3766570

  • 21. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC, Bess DT, Branam AC, Falbe WJ, Mrochek SA, Haymond JD, Stahl AA.
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cost comparison of two systems for intermittent intravenous administration of small-volume injections.
    Reilly RT, Strand LM, Bair JN.
    Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cost considerations in oral antibiotic therapy.
    Ballow CH.
    Adv Ther; 1995 Feb; 12(4):199-206. PubMed ID: 10155348
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cost analysis of an aminoglycoside pharmacokinetic dosing program.
    Schloemer JH, Zagozen JJ.
    Am J Hosp Pharm; 1984 Nov; 41(11):2347-51. PubMed ID: 6507436
    [Abstract] [Full Text] [Related]

  • 32. Fiscal impact of a total nutrient admixture program at a pediatric hospital.
    Eskew JA.
    Am J Hosp Pharm; 1987 Jan; 44(1):111-4. PubMed ID: 3103430
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ.
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J.
    Acta Pol Pharm; 2005 Jul; 62(6):485-90. PubMed ID: 16583989
    [Abstract] [Full Text] [Related]

  • 37. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J.
    Acta Pol Pharm; 2005 Jul; 62(6):491-5. PubMed ID: 16583990
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ, Newton RW, Leduc DT.
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [Abstract] [Full Text] [Related]

  • 40. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
    Opmeer BC, El Moussaoui R, Bossuyt PM, Speelman P, Prins JM, de Borgie CA.
    J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.